Terminal heart failure treatment strategies

References

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J. et al. Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation. 2014; 129 (3): e28–e292. DOI: 10.1161/01.cir.0000441139.02102.80
   
2. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016; 8: 7–13. DOI: 10.15829/15604071-2016-8-7-13 [Fomin I.V. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016; 8: 7–13 (in Russ.). DOI: 10.15829/ 1560-4071-2016-8-7-13 ]
   
3. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П., Коротеев А.В., Ревишвили А.Ш., Васюк Ю.А. и др. Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (второй пересмотр). Журнал Сердечная недостаточность. 2007; 8; 1 (39): 4–41. [Mareev V.Yu., Ageev F.T., Arutyunov G.P., Koroteev A.V., Revishvili A.Sh., Vasyuk Yu.A. et al. RSSC and OSSN National Guidelines on diagnostics and treatment of CHF (second revision). Russian Heart Failure Journal. 2007; 8; 1 (39): 4–41 (in Russ.).]
   
4. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П., КоротеевА.В., Ревишвили А.Ш., Беленков Ю.Н. и др. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр) (утверждены конференцией ОССН 15 декабря 2009 года). Журнал Сердечная недостаточность. 2010; 11; 1 (57): 3–62. [Mareev V.Yu., Ageev F.T., Arutyunov G.P., Koroteev A.V., Revishvili A.Sh., Belenkov Yu.N. et al. National recommendations of VNOK and SSHF on the diagnostics and treatment of chronic heart failure (third review) (Approved by OSSN Conference, December 15, 2009). Russian Heart Failure Journal. 2010; 11; 1 (57): 3–62 (in Russ.).]
   
5.  Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П., Коротеев А.В., Мареев Ю.В., Овчинников А.Г. и др. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Утверждены на Конгрессе ОССН 7 декабря 2012 года, на правлении ОССН 31 марта 2013 года и Конгрессе РКО 25 сентября 2013 года. Журнал Сердечная недостаточность. 2013; 14; 7 (81): 379–472. DOI: 10.18087/rhfj.2013.7.1860 [Mareev V.Yu., Ageev F.T., Arutyunov G.P., Koroteev A.V., Mareev Yu.V., Ovchinnikov A.G. et al. SEHF, RSC and RSMSIM National Guidelines on CHF diagnostics and treatment (forth revision). Approved at the SEHF Congress on December 7, 2012, at the SEHF Board of Directors meeting on March 31, 2013, and at the RSC Congress on September 25, 2013. Russian Heart Failure Journal. 2013; 14; 7 (81): 379–472 (in Russ.). DOI: 10.18087/rhfj.2013.7.1860 ]
   
6. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Арутюнов Г.П., Беграмбекова Ю.Л., Беленков Ю.Н. и др. Хроническая сердечная недостаточность (ХСН). Журнал Сердечная недостаточность. 2017; 18; 1 (100): 3–40. DOI: 10.18087/rhfj.2017.1.2346 [Mareev V.Yu., Fomin I.V., Ageev F.T., Arutyunov G.P., Begrambekova Yu.L., Belenkov Yu.N. et al. Chronic heart failure. Russian Heart Failure Journal. 2017; 18; 1 (100): 3–40 (in Russ.). DOI: 10.18087/rhfj.2017.1.2346 ]
   
7. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Беграмбекова Ю.Л., Васюк Ю.А., Гарганеева А.А. и др. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018; 58 (S6): 8–158. DOI: 10.18087/CARDIO. 2475 [Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A. et al. Russian Heart Failure Society of Cardiology. Russian Scientific Medical Society of Medicine Guidelines for Heart failure: chronic (CHF) and acute decomensated (ADHF). Diagnosis, prevention and tretment. Kardiologiia. 2018; 58 (S6): 8–158 (in Russ.). DOI: 10.18087/cardio. 2475 ]
   
8. Ощепкова Е.В., Довгалевский П.Я., Гриднев В.И., Посненкова О.М., Киселев А.Р., Дмитриев Е.А. и др. Структура первичных элементов базы данных российского регистра больных артериальной гипертонией, ишемической болезнью сердца и хронической сердечной недостаточностью. КардиоИТ. 2014; 1 (2): 202. DOI: 10.15275/cardioit. 2014.0202 [Oshchepkova E.V., Dovgalevsky P.Ya., Gridnev V.I., Posnenkova O.M., Kiselev A.R., Dmitriev E.A. et al. Key data elements and definitions of the Russian registry of patients with arterial hypertension, coronary artery disease and chronic heart failure. Cardio-IT. 2014; 1 (2): 202 (in Russ.). DOI: 10.15275/cardioit. 2014.0202 ]
   
9. Ощепкова Е.В., Довгалевский П.Я., Гриднев В.И., Посненкова О.М., Киселев А.Р., Дмитриев Е.А. и др. Руководство пользователя российского регистра больных артериальной гипертонией, ишемической болезнью сердца и хронической сердечной недостаточностью. Кардио-ИТ. 2014; 1 (2): 204. DOI: 10.15275/cardioit.2014.0204 [Oshchepkova E.V., Dovgalevsky P.Ya., Gridnev V.I., Posnenkova O.M., Kiselev A.R., Dmitriev E.A. et al. User guide of Russian registry of patients with arterial hypertension, coronary artery disease and chronic heart failure. Cardio-IT. 2014; 1 (2): 204 (in Russ.). DOI: 10.15275/cardioit.2014.0204 ]
   
10. Посненкова О.М., Киселев А.Р., Коротин А.С., Генкал Е.Н., Гриднев В.И., Довгалевский П.Я. и др. Публичный отчет о качестве медицинской помощи больным со стабильной ишемической болезнью сердца и хронической сердечной недостаточностью в 2013 году: данные регистра ишемической болезни сердца и хронической сердечной недостаточности по г. Саратову. Кардио-ИТ.2014; 1 (4): 402. DOI: 10.15275/cardioit.2014.0402 [Posnenkova O.M., Kiselev A.R., Korotin A.S., Genkal E.N., Gridnev V.I., Dovgalevsky P.Ya. et al. Public report on quality of care delivered to patients with stable coronary artery disease and chronic heart failure in 2013: the data from Saratov registry of coronary artery disease and chronic heart failure. Cardio-IT. 2014; 1 (4): 402 (in Russ.). DOI: 10.15275/cardioit. 2014.0402 ]
    
11. Коротин А.С., Посненкова О.М., Киселев А.Р., Гриднев В.И., Довгалевский П.Я., Ощепкова Е.В. и др. Выполнение рекомендованных мероприятий медицинской помощи у больных с хронической сердечной недостаточностью: данные российского регистра за 2014 год. Кардио-ИТ. 2015; 2 (1): 0104. DOI: 10.15275/cardioit.2015.0104 [Korotin A.S., Posnenkova O.M., Kiselev A.R., Gridnev V.I., Dovgalevsky P.Ya., Oshchepkova E.V. et al. Implementation of recommended measures in patients with chronic heart failure: the data from 2014 Russian registry. Cardio-IT.2015; 2 (1): 0104 (in Russ.). DOI: 10.15275/cardioit.2015.0104 ]
    
12. De Sutter J., Pardaens S., Audenaert T., Weytjens C., Kerckhove B.V., Willems R.A. et al. Clinical characteristics and short-term outcome of patients admitted with heart failure in Belgium: results from the BIO-HF registry. Acta Cardiol. 2015; 70 (4): 375–85. DOI: 10.1080/ac.70.4.3094645
    
13. Посненкова О.М., Киселев А.Р., Попова Ю.В., Волкова Е.Н., Гриднев В.И., Довгалевский П.Я. и др. Методология клинических индикаторов качества медицинской помощи больным сердечно-сосудистыми заболеваниями. Кардио-ИТ. 2014; 1 (1): 103. DOI: 10.15275/cardioit.2014.0103 [Posnenkova O.M., Kiselev A.R., Popova Yu.V., Volkova E.N., Gridnev V.I., Dovgalevsky P.Ya. et al. Methodology of clinical measures of healthcare quality delivered to patients with cardiovascular diseases. Cardio-IT. 2014; 1 (1): 103 (in Russ.). DOI: 10.15275/cardioit.2014.0103 ]
    
14. Li S.J., Sartipy U., Lund L.H., Dahlstrom U., Adiels M., Petrzold M. et al. Prognostic significance of resting heart rate and use of β-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry. Circ. Heart Fail. 2015; 8 (5): 871–9. DOI: 10.1161/circheartfailure.115.002285
    
15. Cleland J.G., Torabi A., Khan N.K. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart. 2005; 91: ii7–ii13. DOI: 10.1136/hrt.2005.062026
    
16. Gedela M., Khan M., Jonsson O.S. Heart failure. S. D. Med. 2015; 68 (9): 403–5, 407–9. DOI: 10.32474/ OAJBEB.2018.01.000105
    
17. Willenheimer R., van Veldhuisen D.J., Silke B., Erdmann E., Follath F., Krum H. et al. CIBIS III Investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation. 2005; 112 (16): 2426–35. DOI: 10.1161/circulationaha. 105.582320
    
18. Bocchi E.A., Marcondes-Braga F.G., Ayub-FerreiraS.M., Rohde L.E., Oliveira W.A., AlmeidaD.R. et al. Sociedade Brasileira de Cardiologia. III Diretriz Brasileira de Insuficie ^ncia Cardíaca Cronica. Arq. Bras. Cardiol. 2009; 93 (1 Suppl.): 1–71. DOI: 10.5935/ abc.20120101
    
19. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. ESC Scientific Document Group. Eur. Heart J. 2016; 37 (27): 2129–200. DOI: 10.1093/eurheartj/ehw128
20. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 1999; 341 (10): 709–17. DOI: 10.1056/NEJM199909023411001
    
21. Inampudi C., Parvataneni S., Morgan C.J., Deedwania P., Fonarow G.C., Sanders P.W. et al. Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m2. Am. J. Cardiol. 2014; 114 (1): 79–82. DOI: 10.1016/j.amjcard. 2014.03.062
    
22. Ahmed A., Bourge R.C., Fonarow G.C., Patel K., Morgan C.J., Fleg J.L. et al. Digoxin use and lower 30day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. Am. J. Med. 2014; 127 (1): 61–70. DOI: 10.1016/j.amjmed.2013.08.027
    
23. Chen J., Normand S.L., Wang Y., Krumholz H.M. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries,
    
24. 24. Sohaib T., Aronow W.S. Use of inotropic agents in treatment of systolic heart failure. Int. J. Mol. Sc. 2015; 16 (12): 29060–8. DOI: 10.3390/ijms161226147
    
25. Ross J.S., Chen J., Lin Z., Bueno H., Curtis J.P., Keenan P.S. et al. Recent national trends in readmission rates after heart failure hospitalization. Circ. Heart Fail. 2010; 3: 97–103. DOI: 10.1161/circheartfailure. 109.885210
    
26. Shakib S., Clark R.A. Heart failure pharmacotherapy and supports in the elderly – a short review. Curr. Cardiol. Rev. 2016; 12 (3): 180–5. DOI: 10.2174/ 1573403x12666160622102802
    
27. Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Drazner M.H. et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary Cardiol. J. Am. Coll. Cardiol. 2013; 62 (16): 1495–539. DOI: 10.1016/j.jacc.2013.05.020
    
28. Chang P.P., Chambless L.E., Shahar E., Bertoni A.G., Russell S.D., Hanyu Ni et al. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). Am. J. Cardiol. 2014; 113: 504–10. DOI: 10.1016/j.cardfail.2009.06.145
    
29. McMurray J.J., Packer M., Desai A.S., Gong J., Lefkowitz M.P., Rizkala A.R. et al. Angiotensinneprilysin inhibition versus enalapril in heart failure. PARADIGM-HF Investigators and Committees. N. Engl. J. Med. 2014; 371 (11): 993–1004. DOI: 10.1056/ NEJMoa1409077
    
30. Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E. Jr, Colvin M.M. et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016; 134 (13): e282–93. DOI: 10.1161/cir.0000000000000435
    
31. Smith S.A., Abraham W.T. Device therapy in advanced heart failure: what to put in and what to turn off. Remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy. Congest. Heart Fail. 2011; 17: 220–6. DOI: 10.1111/j.1751-7133.2011.00238.x
    
32. Mullens W., Verga T., Grimm R.A. Starling R.C., Wilkoff B.L., Wilson Tang W.H. et al. Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure. J. Am. Coll. Cardiol. 2009; 53: 600–7. DOI: 10.1016/ j.jacc.2008.08.079
    
33. Burkhardt J.D., Wilkoff B.L. Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure. Circulation. 2007; 115: 2208–20. DOI: 10.1161/circulationaha. 106.655712
    
34. Tayal B., Gorcsan J. 3rd, Bax J.J., Risum N., Olsen N.T., Singh J.P. et al. Cardiac resynchronization therapy in heart failure with narrow QRS. J. Am. Coll. Cardiol. 2018; 71 (12): 1325–33. DOI: 10.1016/j.jacc. 2018.01.042
    
35. Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C. et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 2001; 344 (12): 873–80. DOI: 10.1016/s1062-1458(01)00399-3
    
36. Ревишвили А.Ш., Антонченко И.В., Ардашев А.В., Бокерия О.Л., Голухова Е.З., Давтян К.В. и др. Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. М.; 2011. [Revishvili A.Sh., Antonchenko I.V., Ardashev A.V., Bockeria O.L., Golukhova E.Z., Davtyan K.V. et al. Clinical recommendations for electrophysiological studies, catheter ablation and the use of implantable antiarrhythmic devices. Moscow; 2011 (in Russ.).]
    
37. Yu C.-M., Bleeker G.B., Fung J.W.-H., Schalij M.J., Zhang Q., van der Wall E.E. et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation [Internet]. 2005; 112 (11): 1580–6. DOI: 10.1161/circulationaha.105.538272
    
38. Padeletti L., Nesti M., Boriani G. Cardiac resynchronization therapy: state of the art. Heart Fail. Clin. 2017; 13 (1). DOI: 10.1016/s1551-7136(16)30108-8
    
39. Ukkonen H., Beanlands R.S., Burwash I.G., de Kemp R.A., Nahmias C., Fallen E. et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation. 2003; 107 (1): 28–31. DOI: 10.1161/01.cir.0000047068.02226.95
    
40. Orrego C.M., Nadim Nasir, Oliveira G.H., FloresArredondo J.H., Cordero-Reyes A.M., Loebe M. et al. Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy. Congest. Heart Fail. 2011; 17 (3): 140–6. DOI: 10.1111/j.17517133.2011.00227.x
    
41. Garcia-Bolao I., Lopez B., Macias A., Gavira J.J., Azcarate P., Diez J. Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy. Eur. Heart J. 2008; 29 (7): 898–906. DOI: 10.1093/eurheartj/ehn098
    
42. Stoskute N., Vaskelyte J.J., Ereminiene E., Puodziukynas A., Kviesulaitis V., Abramaviciute A. Long term left ventricular reverse remodeling and functional outcome after cardiac resynchronization in advanced heart failure. J. Gen. Pract. 2018; 6 (4). DOI: 10.4172/ 23299126.1000365
    
43. Cazeau S.J., Daubert J.-C., Tavazzi L., Frohlig G., Paul V. Responders to cardiac resynchronization therapy with narrow or intermediate QRS complexes identified by simple echocardiographic indices of dyssynchrony: the DESIRE Study. Eur. J. Heart Fail. 2008; 10 (3): 273–80. DOI: 10.1016/j.ejheart.2008.02.007
    
44. Chung E.S., Leon A.R., Tavazzi L., Sun J.P., Nihoyannopoulos P., Merlino J. et al. Results of the predictors of response to CRT (PROSPECT) Trial. Circulation. 2008; 117 (20): 2608–16. DOI: 10.1161/ circulationaha.107.743120
    
45. Hsu J.C., Solomon S.D., Bourgoun M., McNitt S., Goldenberg I., Klein H. et al. MADIT-CRT Executive Committee. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J. Am. Coll. Cardiol. 2012; 59 (25): 2366–73. DOI: 10.1016/j.jacc.2012.01.065
    
46. Arshad A., Moss A.J., Foster E., Padeletti L., Barsheshet A., Goldenberg I. et al. Cardiac resynchronization therapy is more effective in women than in men. J. Am. Coll. Cardiol. 2011; 57: 813–20. DOI: 10.1016/j.jacc.2010.06.061
    
47. Costanzo M.R. Cardiac resynchronization therapy in women. Heart Fail. Clin. 2017; 13 (1): 165–78. DOI: 10.1016/j.hfc.2016.07.013
    
48. Fulati Z., Liu Y., Sun N., Yu K., Su Y., Chen H. et al. Speckle tracking echocardiography analyses of myocardial contraction efficiency predict response for cardiac resynchronization therapy. Cardiovasc. Ultrasound. 2018; 16 (1): 30. DOI: 10.1186/s12947-018-0148-5
    
49. Bhambhani A., John N., Kumar B., Mathew A. Threedimensional echocardiographic evaluation of mechanical dyssynchrony in systolic heart failure with narrow QRS complex. Indian Heart J. 2018; 70 (3): 387–93. DOI: 10.1016/j.ihj.2017.10.013
    
50. Linde C., Abraham W.T., Gold M.R., St John Sutton M., Ghio S., Daubert C. REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptoatic patients with left ventricular dysfunction and previous heart failure symptoms. J. Am. Coll. Cardiol. 2008; 52 (23): 1834–43. DOI: 10.1016/ j.jacc.2008.08.027
    
51. Gold M.R. Cardiac-resynchronization therapy for the prevention of heart-failure events. Yearb. Cardiol. 2010; 554–6. DOI: 10.1016/s0145-4145(10)79890-7
    
52. Doost S.N., Zhong L., Morsi Y.S. Ventricular assist devices: current state and challenges. ASME. J. Med. Devices. 2017; 11 (4): 040801. DOI: 10.1115/1.4037258
    
53. Liotta D., Hall C.W., Henly W.S., Cooley D.A., Crawford E.S., Debakey M.E. Prolonged assisted circulation during and after cardiac or aortic surgery prolonged partial left ventricular bypass by means of intracorporeal circulation. Am. J. Cardiol. 1963; 12: 399–405.
    
54. McCarthy P.M., Sabik J.F. Implantable circulatory support devices as a bridge to heart transplantation. Semin. Thorac. Cardiovasc. Surg. 1994; 6 (3): 174–80.
    
55. Rogers J.G., Aaronson K.D., Boyle A.J., Russell S.D., Milano C.A., Pagani F.D. et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J. Am. Coll. Cardiol. 2010; 55: 1826–34. DOI: 10.1016/j.jacc.2009.12.052
    
56. Takeda K., Takayama H., Kalesan B., Uriel N., Colombo P.C., Jorde U.P. et al. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. J. Heart Lung Transplant. [Internet]. 2015; 34 (1): 89–99. DOI: 10.1016/j.healun.2014.09.007
    
57. Jessup M., Drazner M.H., Book W., Cleveland J.C., Dauber I., Farkas S. et al. 2017 ACC/AHA/HFSA/ ISHLT/ACP Advanced training statement on advanced heart failure and transplant cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): a report of the ACC Competency Management Committee. Circ. Heart Fail. [Internet]. 2017; 10 (6). DOI: 10.1161/ hhf.0000000000000021
    
58. Pierce W.S., Parr G.V., Myers J.L., Pae W.E. Jr, Bull A.P., Waldhausen J.A. еt al. Ventricular-assist pumping patients with cardiogenic shock after cardiac operations. N. Engl. J. Med. 1981; 305 (27); 1606–10. DOI: 10.1056/nejm198112313052702
    
59. Feldman D., Pamboukian S.V., Teuteberg J.J., Birks E., Lietz K., Moore S. A. et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J. Heart Lung. Transplant. 2013; 32: 157–87. DOI: 10.1016/j.healun. 2012.09.013
60. Baumwol J., Lam K., Maiorana A.J. Successful explant of a continuous-flow left ventricular assist device after two years of circulatory support. Artific. Org. [Internet]. 2014; 38 (9): 823–4. DOI: 10.1111/aor.12286
    
61. Hardy J. The first lung transplant in man (1963) and the first heart transplant in man (1964). Transplan. Proc. [Internet]. 1999; 31 (1–2): 25–9. DOI: 10.1016/s00411345(98)02059-4
    
62. Reitz B.A., Wallwork J.L., Hunt S.A., Pennock J.L., Billingham M.E., Oyer P.E. et al. Heart-lung transplantation. N. Engl. J. Med. [Internet]. 1982; 306 (10): 557–64. DOI: 10.1056/nejm198203113061001
63. Бураковский В.И., Бокерия Л.А. (ред.) Сердечнососудистая хирургия. М.: Медицина; 1989. [Burakovsky V.I., Bockeria L.A. (Eds) Cardiovascular surgery. Moscow: Meditsina; 1989 (in Russ.).]
    
64. Mehra M.R., Canter C.E., Hannan M.M., Semigran M.J., Uber P.A., Baran D.A. et al. The 2016 International Society for Heart Lung Transplantation Listing Criteria for Heart Transplantation: a 10-year update. J. Heart Lung Transplant. 2016; 35 (1): 1–23. DOI: 10.1016/j.healun.2015.10.023
    
65. Lund L.H., Khush K.K., Cherikh W.S., Goldfarb S., Kucheryavaya A.Y., Levvey B.J. et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report – 2017. Focus theme: allograft ischemic time. J. Heart Lung. Transplant. 2017; 36: 1037–46. DOI: 10.1016/j.healun.2017.07.016
    
66. Lund L.H., Edwards L.B., Dipchand A.I., Goldfarb S., Kucheryavaya A.Y., Levvey B.J. et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation report – 2016. Focus theme: primary diagnostic indications for transplant. J. Heart Lung. Transplant. 2016; 35 (10): 1158–69. DOI: 10.1016/j.healun.2016.08.017
    
67. Khush K.K., Zaroff J.G., Nguyen J., Menza R., Goldstein B.A. National decline in donor heart utilization with regional variability: 1995–2010. Am. J. Transplant. 2015; 15 (3): 642–9. DOI: 10.1111/ajt.13055
    
68. Vaseghi M., Lellouche N., Ritter H., Fonarow G.C., PatelJ.K., Moriguchi J. et al. Mode and mechanisms of death after orthotopic heart transplantation. Heart Rhythm. 2009; 6: 503–9. DOI: 10.1016/j.hrthm.2009.01.005
    
69. Pierce G.L., Schofield R.S., Nichols W.W., Hill J.A., Braith R.W. Role of heart failure etiology on arterial wave reflection in heart transplant recipients: relation with C-reactive protein. J. Hypertens. 2007; 25 (11): 2273–9. DOI: 10.1097/HJH.0b013e3282efec70
    
70. Patel A.R., Kuvin J.T., Pandian N.G., Smith J.J., Udelson J.E., Mendelsohn M.E. et al. Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation. J. Am. Coll. Cardiol. [Internet]. 2001; 37 (1): 195–200. DOI: 10.1016/ s0735-1097(00)01057-3

About Authors